Louisville Medicine Volume 61, Issue 10 | Page 36

Doctors’ Lounge (continued from page 33) vidual patient have supported this stance. But the proposed rule for 2015 will limit antidepressants to 15 drugs. As of 2016 the antipsychotic class would be in jeopardy (CMS may be waiting to see first the effect of limiting antidepressants). Immunosuppressants will no longer be “protected” and that means that insurance companies will have a free hand in denying the branded ones. We already know what happens when patients well stabilized on certain drugs hit the doughnut hole and run out of their medications: they end up in the hospital, or on the street, or in jail. A 2013 study of more than 180,000 people with bipolar disorder or schizophrenia showed that costs attributed to loss of coverage were related to increased hospitalization, and that people who had continuing funds for generic medications had lower costs and better health outcomes. As for the medically ill, who run out of insulin, anticoagu [